Omega-3 Index and Obstructive Sleep Apnea: A Cross-Sectional Study | Zendy

Janine Tittus | Zendy; Marie Theres Huber | Zendy; Klaus Storck | Zendy; Anton Köhler | Zendy; Jan M. Köhler | Zendy; Thomas von Arnim | Zendy; Clemens von Schacky | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Omega-3 Index and Obstructive Sleep Apnea: A Cross-Sectional Study

Author(s) -

Janine Tittus,

Marie Theres Huber,

Klaus Storck,

Anton Köhler,

Jan M. Köhler,

Thomas von Arnim,

Clemens von Schacky

Publication year - 2017

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.6754

Subject(s) - obstructive sleep apnea , medicine , body mass index , eicosapentaenoic acid , docosahexaenoic acid , anthropometry , apnea–hypopnea index , omega 3 fatty acid , sleep apnea , physical therapy , polysomnography , apnea , fatty acid , polyunsaturated fatty acid , chemistry , organic chemistry

Erythrocyte levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Omega-3 Index) were previously found to be associated with obstructive sleep apnea (OSA) at very low levels (< 5.0%) in only one epidemiologic study. OSA has comorbidities, such as arterial hypertension, heart failure, or major depression, also associated with a low Omega-3 Index. These comorbidities can be improved by increasing intake of EPA and DHA, and thus the Omega-3 Index, preferably to its target range of 8% to 11%. Symptoms of OSA might improve by increasing the Omega-3 Index, but more research is needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research